$MTVA Up 49% Premarket! 🚀 🔹 MetaVia catching major momentum off obesity data buzz 📈 🔹 DA-1726 showed 9.1% weight loss in a Phase 1 cohort, with glucose + li

$MTVA Up 49% Premarket! 🚀 🔹 MetaVia catching major momentum off obesity data buzz 📈 🔹 DA-1726 showed 9.1% weight loss in a Phase 1 cohort, with glucose + liver marker improvements 🧬 🔹 GLP-1/glucagon dual agonist angle has traders watching this one closely as obesity names stay hot 🔥 Eyes on $…